Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
Oct 27,2022
Set sail, create a better future! Guangdong Weishi Bio Brings New Products to CACLP 2022
Nov 08,2022
Solid waste pollution prevention and control information disclosure in 2022 (third quarter)
Nov 15,2022
More than 50% of Chinese adults have diabetes or are in the pre-disease stage. See here for diagnostic criteria.
Nov 21,2022
"Only" innovation, win the future! Guangdong Weishi biological new products unveiled in 2022 Germany MEDICA medical exhibition
Nov 24,2022
Together, set sail-Guangdong only real biological new corporate promotional film officially released!
Dec 12,2022
Statement
Feb 03,2023
Performance Evaluation Report of Guangdong Weishi Bio-new Generation of Hypersensitive Cardiac Troponin I(hs-cTnI)
Apr 25,2023
2022.01~2022.12 Solid Waste Pollution Prevention and Control Information Disclosure
Aug 14,2023
2023.01~2023.03 Solid Waste Pollution Prevention and Control Information Disclosure